This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked TFR2 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-TFR2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~88.8 kDa | |
| Gel | 8–10% (standard starting point) | |
| Positive control | Liver (IHC candidate; verify WB) | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Glycosylated | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 3 isoform(s) |
The M02353-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | HepG2 cell lysate (catalog M02353-1) |
| Gel % | 8–10% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | M02353-1; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
The predicted TFR2 monomer is 88.8 kDa; glycans, homodimerization and isoforms may affect migration, but no band position is demonstrated.
| Band near 88.8 kDa | Consistent with the predicted TFR2 monomer; identity requires confirmation. |
| Band above 88.8 kDa | N-linked glycosylation at Asn240, Asn339, Asn540 and Asn754 could affect migration; a shift is not established. |
| Band near 178 kDa under nonreducing conditions | Consistent with a disulfide-linked TFR2 homodimer. |
| Several bands at different sizes | Alpha, Beta and Gamma isoforms are possible contributors; distinct migration is not established. |
| Predicted monomer mass | Sets an 88.8 kDa reference, not a validated band position. |
| N-linked glycosylation at Asn240, Asn339, Asn540 and Asn754 | May alter apparent size; the size of any shift is unknown. |
| Disulfide-linked homodimer | May yield a band near twice the monomer mass without complete reduction. |
| Alpha, Beta and Gamma isoforms | May differ in size; their masses and migration are not supplied. |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | TFR2 is a single-pass membrane protein and may be poorly recovered. | Check membrane extraction and a membrane-protein control. |
| Band higher than expected | A disulfide-linked homodimer may persist with incomplete reduction; N-linked glycans may also affect migration. | Compare reducing conditions and test deglycosylation. |
| Band lower than expected | An alternative isoform could differ in size, but its migration is unknown. | Check isoform coverage and confirm identity with a second antibody. |
| Broad smear instead of sharp band | Variation in N-linked glycosylation is possible but unproven. | Compare untreated and deglycosylated samples. |
| Multiple bands | Alpha, Beta and Gamma isoforms or different oligomeric states may contribute. | Compare reducing conditions and confirm bands with a second antibody. |
| Weak or no signal | Membrane-protein extraction may be inefficient. | Check lysate preparation and loading with a membrane-protein control. |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Liver | hepatocytes | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Breast | adipocytes | Not detected | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | Not detected | Protein (IHC) | HPA → |
| Caudate | glial cells | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for TFR2, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
The catalog reports one anti-TFR2 antibody for Western blotting: M02353-1, a rabbit monoclonal with reported human reactivity. Its WB image shows Transferrin Receptor 2 expression in HepG2 cell lysate; evidence for other samples is not supplied.
Which to pick: M02353-1 is the only listed option. Its HepG2 cell lysate WB image provides a tested context for human TFR2; check suitability separately for other samples.